Clozapine benefits those with tx-resistant schizophrenia

December 1, 2015
Clozapine benefits those with tx-resistant schizophrenia

(HealthDay)—Clozapine reduces symptoms in patients with schizophrenia who don't benefit from other antipsychotic medications, according to research published online Nov. 6 in The American Journal of Psychiatry.

The findings were culled from an analysis of Medicaid data on 6,246 patients with treatment-resistant . The researchers assessed outcomes of a cohort of patients with schizophrenia and evidence of treatment resistance that initiated clozapine (3,123 patients) and in a propensity score-matched cohort that initiated a standard antipsychotic (3,123 patients).

The researchers found that those on clozapine had fewer hospitalizations, stayed on their new medication longer, and were less likely to need to use additional antipsychotics.

"These results give clinicians important guidance for how to help an extremely vulnerable group of people," study author T. Scott Stroup, M.D., M.P.H., a professor of psychiatry at the Columbia University Medical Center in New York City and a research psychiatrist at New York State Psychiatric Institute, said in a Columbia news release. "By helping individuals with treatment-resistant schizophrenia get effective treatment sooner, we can expect better outcomes."

Explore further: Better options for people with treatment-resistant schizophrenia

More information: Full Text (subscription or payment may be required)

Related Stories

Better options for people with treatment-resistant schizophrenia

November 6, 2015
In real-world settings, patients with schizophrenia whose symptoms do not respond to standard antipsychotic medications have better outcomes if they are switched to clozapine instead of another standard antipsychotic. They ...

Antipsychotics initiated frequently and used for long term in Alzheimer's patients

October 14, 2015
Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population - already 2-3 years before the Alzheimer's diagnosis, according to a new study from the University ...

Do antipsychotic medications affect cortical thinning?

September 3, 2015
People diagnosed with schizophrenia critically rely upon treatment with antipsychotic medications to manage their symptoms and help them function at home and in the workplace.

Researchers use brain scans to predict response to antipsychotic medications

August 28, 2015
Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue ...

Research may explain why some people with schizophrenia do not respond to treatment

November 29, 2012
(Medical Xpress)—New research suggests that the molecular mechanism leading to schizophrenia may be different in patients who fail to respond to anti-psychotic medication compared to patients who do respond.

Recommended for you

Itsy bitsy spider: Fear of spiders and snakes is deeply embedded in us

October 19, 2017
Snakes and spiders evoke fear and disgust in many people, even in developed countries where hardly anybody comes into contact with them. Until now, there has been debate about whether this aversion is innate or learnt. Scientists ...

Inflamed support cells appear to contribute to some kinds of autism

October 18, 2017
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues in Brazil, say innate ...

Study suggests psychedelic drugs could reduce criminal behavior

October 18, 2017
Classic psychedelics such as psilocybin (often called magic mushrooms), LSD and mescaline (found in peyote) are associated with a decreased likelihood of antisocial criminal behavior, according to new research from investigators ...

Taking probiotics may reduce postnatal depression

October 18, 2017
Researchers from the University of Auckland and Otago have found evidence that a probiotic given in pregnancy can help prevent or treat symptoms of postnatal depression and anxiety.

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

Schizophrenia disrupts the brain's entire communication system, researchers say

October 17, 2017
Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.